FDA approves $3.2 million gene therapy for rare muscular dystrophy in 4–5-year-olds

Share is caring

The first gene therapy intended to cure a rare and debilitating muscle illness has been granted permission by the Food and Drug Administration of the United States. However, this approval is only valid for children

The first gene therapy intended to cure a rare and debilitating muscle illness has been granted permission by the Food and Drug Administration of the United States. However, this approval is only valid for children 


Share is caring

Similar Posts

Leave a Reply